138 related articles for article (PubMed ID: 16571953)
1. Changing outcome from aneurysmal subarachnoid hemorrhage: another step closer.
Warner DS; Laskowitz DT
Anesthesiology; 2006 Apr; 104(4):629-30. PubMed ID: 16571953
[No Abstract] [Full Text] [Related]
2. Prognosis value of plasma S100B protein levels after subarachnoid aneurysmal hemorrhage.
Weiss N; Sanchez-Peña P; Roche S; Beaudeux JL; Colonne C; Coriat P; Puybasset L
Anesthesiology; 2006 Apr; 104(4):658-66. PubMed ID: 16571959
[TBL] [Abstract][Full Text] [Related]
3. S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage.
Sanchez-Peña P; Pereira AR; Sourour NA; Biondi A; Lejean L; Colonne C; Boch AL; Al Hawari M; Abdennour L; Puybasset L
Crit Care Med; 2008 Aug; 36(8):2267-73. PubMed ID: 18596638
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Early S100 Calcium Binding Protein B and Neuron-Specific Enolase in Patients with Poor-Grade Aneurysmal Subarachnoid Hemorrhage: A Pilot Study.
Abboud T; Mende KC; Jung R; Czorlich P; Vettorazzi E; Priefler M; Kluge S; Westphal M; Regelsberger J
World Neurosurg; 2017 Dec; 108():669-675. PubMed ID: 28943424
[TBL] [Abstract][Full Text] [Related]
5. Predictors of 1-year outcome after coiling for poor-grade subarachnoid aneurysmal hemorrhage.
Pereira AR; Sanchez-Peña P; Biondi A; Sourour N; Boch AL; Colonne C; Lejean L; Abdennour L; Puybasset L
Neurocrit Care; 2007; 7(1):18-26. PubMed ID: 17657653
[TBL] [Abstract][Full Text] [Related]
6. Effect of magnesium sulfate therapy on patients with aneurysmal subarachnoid hemorrhage using serum S100B protein as a prognostic marker.
Hassan T; Nassar M; Elhadi SM; Radi WK
Neurosurg Rev; 2012 Jul; 35(3):421-7; discussion 427. PubMed ID: 22170177
[TBL] [Abstract][Full Text] [Related]
7. The Role of ABO Blood Group in Cerebral Vasospasm, Associated Intracranial Hemorrhage, and Delayed Cerebral Ischemia in 470 Patients with Subarachnoid Hemorrhage.
Dubinski D; Won SY; Konczalla J; Mersmann J; Geisen C; Herrmann E; Seifert V; Senft C
World Neurosurg; 2017 Jan; 97():532-537. PubMed ID: 27777156
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin decreases computed tomography and S100-assessed brain ischemia after subarachnoid aneurysmal hemorrhage: a comparative study.
Sanchez-Peña P; Nouet A; Clarençon F; Colonne C; Jean B; Le Jean L; Fonfrede M; Aout M; Vicaut E; Puybasset L
Crit Care Med; 2012 Feb; 40(2):594-602. PubMed ID: 21926584
[TBL] [Abstract][Full Text] [Related]
9. Statins as neuroprotectants after subarachnoid hemorrhage.
Bhardwaj A
Crit Care Med; 2012 Feb; 40(2):695-7. PubMed ID: 22249060
[No Abstract] [Full Text] [Related]
10. The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage.
Moritz S; Warnat J; Bele S; Graf BM; Woertgen C
J Neurosurg Anesthesiol; 2010 Jan; 22(1):21-31. PubMed ID: 20027011
[TBL] [Abstract][Full Text] [Related]
11. Delayed progressive restenosis of the supraclinoid internal carotid artery treated with percutaneous transluminal angioplasty in a patient with aneurysmal subarachnoid hemorrhage.
Hsu DP; Hu YC; Bambakidis NC
J Neurointerv Surg; 2009 Dec; 1(2):175-8. PubMed ID: 21994293
[TBL] [Abstract][Full Text] [Related]
12. Comparison of plasma copeptin and multiple biomarkers for assessing prognosis of patients with aneurysmal subarachnoid hemorrhage.
Zheng YK; Dong XQ; Du Q; Wang H; Yang DB; Zhu Q; Che ZH; Shen YF; Jiang L; Hu W; Wang KY; Yu WH
Clin Chim Acta; 2017 Dec; 475():64-69. PubMed ID: 29037840
[TBL] [Abstract][Full Text] [Related]
13. An admission bioclinical score to predict 1-year outcomes in patients undergoing aneurysm coiling.
Degos V; Apfel CC; Sanchez P; Colonne C; Renuit I; Clarençon F; Nouet A; Boch AL; Pourmohamad T; Kim H; Gourraud PA; Young WL; Puybasset L
Stroke; 2012 May; 43(5):1253-9. PubMed ID: 22363051
[TBL] [Abstract][Full Text] [Related]
14. The use of S100B as a biomarker in subarachnoid hemorrhage: clarity in its promise and limits.
Laskowitz DT; Warner DS
Crit Care Med; 2008 Aug; 36(8):2452-3. PubMed ID: 18664797
[No Abstract] [Full Text] [Related]
15. Endovascular treatment of intracranial aneurysms and vasospasm after aneurysmal subarachnoid hemorrhage.
Hanel RA; Lopes DK; Wehman JC; Sauvageau E; Levy EI; Guterman LR; Hopkins LN
Neurosurg Clin N Am; 2005 Apr; 16(2):317-53, ix. PubMed ID: 15694165
[No Abstract] [Full Text] [Related]
16. S-100B and NSE: markers of initial impact of subarachnoid haemorrhage and their relation to vasospasm and outcome.
Oertel M; Schumacher U; McArthur DL; Kästner S; Böker DK
J Clin Neurosci; 2006 Oct; 13(8):834-40. PubMed ID: 16931022
[TBL] [Abstract][Full Text] [Related]
17. Triple H therapy after aneurysmal subarachnoid hemorrhage. A review.
Romner B; Reinstrup P
Acta Neurochir Suppl; 2001; 77():237-41. PubMed ID: 11563296
[No Abstract] [Full Text] [Related]
18. Which treatment modality is more injurious to the brain in patients with subarachnoid hemorrhage? Degree of brain damage assessed by serum S100 protein after aneurysm clipping or coiling.
Shim JH; Yoon SM; Bae HG; Yun IG; Shim JJ; Lee KS; Doh JW
Cerebrovasc Dis; 2012; 34(1):38-47. PubMed ID: 22759541
[TBL] [Abstract][Full Text] [Related]
19. Increased GFAP and S100beta but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity.
Vos PE; van Gils M; Beems T; Zimmerman C; Verbeek MM
Eur J Neurol; 2006 Jun; 13(6):632-8. PubMed ID: 16796588
[TBL] [Abstract][Full Text] [Related]
20. Adrenomedullin in patients with cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Fujioka M; Nishio K; Sakaki T; Minamino N; Kitamura K
Stroke; 2000 Dec; 31(12):3079-83. PubMed ID: 11108778
[No Abstract] [Full Text] [Related]
[Next] [New Search]